AM PHARMA

AmPharma specializes in the marketing, distribution, and manufacturing of pharmaceutical products with a focus on addressing cardiac surgery-associated renal damage (CSA-RD), which occurs in 40% of all cardiac surgeries. The company offers a range of products, including a potent antiviral, a synergistic amphicholine, a choline chloride source and lipotropic agent for poultry and livestock, high phosphorus supplements for bone development, and AMPHIMETHIONINE powder as a methionine donor for poultry and farm animals. AmPharma aims to improve health outcomes in both human healthcare and animal husbandry through its proprietary solutions.